Scarica l'app Stockscreener
3.34
1.18%
-0.04
Dopo l'orario di chiusura:
3.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$3.38
Aprire:
$3.38
Volume 24 ore:
4.10M
Relative Volume:
1.01
Capitalizzazione di mercato:
$862.35M
Reddito:
$427.68M
Utile/perdita netta:
$-58.06M
Rapporto P/E:
-14.02
EPS:
-0.2382
Flusso di cassa netto:
$-37.50M
1 W Prestazione:
-2.34%
1M Prestazione:
-12.11%
6M Prestazione:
-43.77%
1 anno Prestazione:
-36.38%
Intervallo 1D:
$3.29
$3.40
Intervallo di 1 settimana:
$3.29
$3.46
Portata 52W:
$3.29
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.34 | 883.00M | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
ARDX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Ardelyx (AR - The National Law Review
ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026 - TradingView
Securities Lawsuit Alert: Ardelyx, Inc. (ARDX) InvestorsContact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Ardelyx stock falls 18% after Q2 miss and XPHOZAH target withdrawal - scanx.trade
Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in XTI Aerospace, Inc. of Class Action Lawsuit and Upcoming Deadlines – XTIA - GlobeNewswire Inc.
Debt to equity ratio of Ardelyx, Inc. – HAN:41X - TradingView
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - The Conway Daily Sun
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ardelyx, - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Ardelyx Inc Lobbyists, 2025 - OpenSecrets
ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline - GlobeNewswire
Ardelyx Inc Hired Firms, 2025 - OpenSecrets
Kaplan Fox Reminds Investors of Ardelyx, Inc. (NASDAQ: ARDX) to a - The National Law Review
Investor Alert: Deadline Approaching to Join Ardelyx, Inc. (ARDX) Class ActionContact Levi & Korsinsky - ACCESS Newswire
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors – Lead Plaintiff Deadline November 16, 2026 - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. - GlobeNewswire
ARDX ALERT: Securities Fraud Class Action Launched Against Ardelyx, Inc.November 16, 2026 Deadline - ACCESS Newswire
ARDELYX INC (ARDX) Stock Chart - ChartMill
Levi & Korsinsky Urges Ardelyx, Inc. (ARDX) Shareholders to Act Before Lead Plaintiff Deadline November 16, 2026 - ACCESS Newswire
Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) t - The National Law Review
Ardelyx, Inc. (ARDX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 16, 2026 Deadline - ACCESS Newswire
November 16, 2026 Deadline Approaching: Join Class Action Against Ardelyx, Inc. (ARDX)Contact Levi & Korsinsky - ACCESS Newswire
Investors in Ardelyx, Inc. (ARDX): Protect Your RightsContact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
Lost Money on Ardelyx, Inc. (ARDX)? Contact Levi & Korsinsky Before November 16, 2026 to Join Class Action - ACCESS Newswire
ARDX Class Action ReminderRobbins LLP Reminds Investors - GlobeNewswire
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Encourages Investors of Ardelyx, Inc. (NASDAQ: ARDX) to Contact the Firm to Learn About Their Legal Rights - The Globe and Mail
ARDX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ar - The National Law Review
Did You Lose Money on Ardelyx, Inc. (ARDX)? Levi & Korsinsky Urges Investors to Act Before November 16, 2026 - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming DeadlinesARDX - PR Newswire
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Portnoy Law Firm Announces Class Action on Behalf of Ardelyx, Inc. Investors - GlobeNewswire
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. LawsuitARDX - PR Newswire
ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Lawsuit Filed: Ardelyx, Inc. (ARDX)Join by November 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026ARDX - PR Newswire
Uncovering Potential: Penny Stocks To Watch In September 2026 - simplywall.st
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Securities Lawsuit Alert: Ardelyx, Inc. (ARDX)Contact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Rosen Law Firm Urges Ardelyx, Inc. (NASDAQ: ARDX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Ardelyx puts lessons from FDA’s Untitled Letters into practice in first Ibsrela TV campaign - Medical Marketing and Media
Class action filed against Ardelyx over misleading growth claims, stock drops 18% after revenue guidance cut. - Pluang
ARDX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Ardelyx (A - The National Law Review
Investors in Ardelyx face lawsuit over alleged misleading revenue guidance and stock drop. - Pluang
Class action lawsuit filed against Ardelyx over misleading statements on drug sales and patient access. - Pluang
Ardelyx Targets $500M Revenue This Year, Profitability by 2027 - TradingView
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ardelyx Inc Azioni (ARDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Reilly Joseph James | See Remarks |
Aug 21 '26 |
Sale |
3.86 |
3,982 |
15,358 |
145,854 |
| Bishop John E | See Remarks |
Aug 21 '26 |
Sale |
3.86 |
19,750 |
76,174 |
317,095 |
| Brady James Parker | Chief Human Resources Officer |
Aug 21 '26 |
Sale |
3.86 |
15,136 |
58,378 |
245,930 |
| Foster Eric Duane | Chief Commercial Officer |
Aug 21 '26 |
Sale |
3.86 |
8,562 |
33,023 |
409,410 |
| Kelliher Mike | Chief Business Officer |
Aug 21 '26 |
Sale |
3.86 |
7,758 |
29,922 |
349,660 |
| Williams Laura A | Chief Patient Officer |
Aug 21 '26 |
Sale |
3.86 |
10,739 |
41,419 |
367,456 |
| RAAB MICHAEL | President & CEO |
Aug 21 '26 |
Sale |
3.86 |
58,574 |
225,914 |
1,619,792 |
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):